 | • レポートコード：MRC2012A6818 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、副甲状腺ホルモンアナログの世界市場を広く調査・分析し、今後の市場展望をまとめております。副甲状腺ホルモンアナログの種類別市場規模（アバロパラチド、テリパラチド、ヒト副甲状腺ホルモン組換え体）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Cell Genesys Inc、Natpara、Abbott Laboratories、Eli Lilly、Merck、Paladin Labs Inc、Sanofi SA、GlaxoSmithKline Plc、OSI Pharmaceuticals、ALZA Corporation、 ・地域別グローバル市場分析 2015年-2020年 ・副甲状腺ホルモンアナログの北米市場（アメリカ、カナダ、メキシコ） ・副甲状腺ホルモンアナログのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・副甲状腺ホルモンアナログのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・副甲状腺ホルモンアナログの南米市場（ブラジル、アルゼンチン） ・副甲状腺ホルモンアナログの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アバロパラチド、テリパラチド、ヒト副甲状腺ホルモン組換え体 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Parathyroid Hormone Analog market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Parathyroid Hormone Analog market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Parathyroid Hormone Analog market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Parathyroid Hormone Analog market has been segmented into
Abaloparatide
Teriparatide
Human Parathyroid Hormone Recombinant
By Application, Parathyroid Hormone Analog has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Parathyroid Hormone Analog market presented in the report. This section sheds light on the sales growth of different regional and country-level Parathyroid Hormone Analog markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Parathyroid Hormone Analog market.
The report offers in-depth assessment of the growth and other aspects of the Parathyroid Hormone Analog market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Parathyroid Hormone Analog Market Share Analysis
Parathyroid Hormone Analog competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Parathyroid Hormone Analog sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Parathyroid Hormone Analog sales, revenue and market share for each player covered in this report.
The major players covered in Parathyroid Hormone Analog are:
Pfizer
Cell Genesys Inc
Natpara
Abbott Laboratories
Eli Lilly
Merck
Paladin Labs Inc
Sanofi SA
GlaxoSmithKline Plc
OSI Pharmaceuticals
ALZA Corporation
Among other players domestic and global, Parathyroid Hormone Analog market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parathyroid Hormone Analog product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Parathyroid Hormone Analog, with price, sales, revenue and global market share of Parathyroid Hormone Analog in 2018 and 2019.
Chapter 3, the Parathyroid Hormone Analog competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parathyroid Hormone Analog breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Parathyroid Hormone Analog market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Parathyroid Hormone Analog sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Parathyroid Hormone Analog Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parathyroid Hormone Analog Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Abaloparatide
1.2.3 Teriparatide
1.2.4 Human Parathyroid Hormone Recombinant
1.3 Market Analysis by Application
1.3.1 Overview: Global Parathyroid Hormone Analog Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Overview of Global Parathyroid Hormone Analog Market
1.4.1 Global Parathyroid Hormone Analog Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cell Genesys Inc
2.2.1 Cell Genesys Inc Details
2.2.2 Cell Genesys Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cell Genesys Inc SWOT Analysis
2.2.4 Cell Genesys Inc Product and Services
2.2.5 Cell Genesys Inc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Natpara
2.3.1 Natpara Details
2.3.2 Natpara Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Natpara SWOT Analysis
2.3.4 Natpara Product and Services
2.3.5 Natpara Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott Laboratories SWOT Analysis
2.4.4 Abbott Laboratories Product and Services
2.4.5 Abbott Laboratories Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Paladin Labs Inc
2.7.1 Paladin Labs Inc Details
2.7.2 Paladin Labs Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Paladin Labs Inc SWOT Analysis
2.7.4 Paladin Labs Inc Product and Services
2.7.5 Paladin Labs Inc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi SA
2.8.1 Sanofi SA Details
2.8.2 Sanofi SA Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SA SWOT Analysis
2.8.4 Sanofi SA Product and Services
2.8.5 Sanofi SA Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline Plc
2.9.1 GlaxoSmithKline Plc Details
2.9.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline Plc SWOT Analysis
2.9.4 GlaxoSmithKline Plc Product and Services
2.9.5 GlaxoSmithKline Plc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 OSI Pharmaceuticals
2.10.1 OSI Pharmaceuticals Details
2.10.2 OSI Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 OSI Pharmaceuticals SWOT Analysis
2.10.4 OSI Pharmaceuticals Product and Services
2.10.5 OSI Pharmaceuticals Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 ALZA Corporation
2.11.1 ALZA Corporation Details
2.11.2 ALZA Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 ALZA Corporation SWOT Analysis
2.11.4 ALZA Corporation Product and Services
2.11.5 ALZA Corporation Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Parathyroid Hormone Analog Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Parathyroid Hormone Analog Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Parathyroid Hormone Analog Manufacturer Market Share in 2019
3.3.2 Top 6 Parathyroid Hormone Analog Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Parathyroid Hormone Analog Sales, Revenue and Market Share by Regions
4.1.1 Global Parathyroid Hormone Analog Sales and Market Share by Regions (2015-2020)
4.1.2 Global Parathyroid Hormone Analog Revenue and Market Share by Regions (2015-2020)
4.2 North America Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.3 Europe Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.5 South America Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
5.1.1 North America Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
5.1.2 North America Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
5.2 United States Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
5.3 Canada Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
5.4 Mexico Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
6.1.1 Europe Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
6.1.2 Europe Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
6.2 Germany Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.3 UK Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.4 France Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.5 Russia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.6 Italy Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Parathyroid Hormone Analog Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Parathyroid Hormone Analog Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Parathyroid Hormone Analog Revenue and Market Share by Regions (2015-2020)
7.2 China Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.3 Japan Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.4 Korea Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.5 India Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.7 Australia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
8.1.1 South America Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
8.1.2 South America Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
8.2 Brazil Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
8.3 Argentina Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9.3 Turkey Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9.4 Egypt Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9.5 South Africa Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Parathyroid Hormone Analog Sales and Market Share by Type (2015-2020)
10.2 Global Parathyroid Hormone Analog Revenue and Market Share by Type (2015-2020)
10.3 Global Parathyroid Hormone Analog Price by Type (2015-2020)
11 Global Parathyroid Hormone Analog Market Segment by Application
11.1 Global Parathyroid Hormone Analog Sales Market Share by Application (2015-2020)
11.2 Global Parathyroid Hormone Analog Revenue Market Share by Application (2015-2020)
11.3 Global Parathyroid Hormone Analog Price by Application (2015-2020)
12 Market Forecast
12.1 Global Parathyroid Hormone Analog Sales, Revenue and Growth Rate (2021-2025)
12.2 Parathyroid Hormone Analog Market Forecast by Regions (2021-2025)
12.2.1 North America Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.2 Europe Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.3 Asia-Pacific Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.4 South America Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.5 Middle East & Africa Parathyroid Hormone Analog Market Forecast (2021-2025)
12.3 Parathyroid Hormone Analog Market Forecast by Type (2021-2025)
12.3.1 Global Parathyroid Hormone Analog Sales Forecast by Type (2021-2025)
12.3.2 Global Parathyroid Hormone Analog Market Share Forecast by Type (2021-2025)
12.4 Parathyroid Hormone Analog Market Forecast by Application (2021-2025)
12.4.1 Global Parathyroid Hormone Analog Sales Forecast by Application (2021-2025)
12.4.2 Global Parathyroid Hormone Analog Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Parathyroid Hormone Analog Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Parathyroid Hormone Analog by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Parathyroid Hormone Analog Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Parathyroid Hormone Analog Major Business
Table 9. Pfizer Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Parathyroid Hormone Analog Product and Services
Table 12. Pfizer Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Cell Genesys Inc Basic Information, Manufacturing Base and Competitors
Table 14. Cell Genesys Inc Parathyroid Hormone Analog Major Business
Table 15. Cell Genesys Inc Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 16. Cell Genesys Inc SWOT Analysis
Table 17. Cell Genesys Inc Parathyroid Hormone Analog Product and Services
Table 18. Cell Genesys Inc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Natpara Basic Information, Manufacturing Base and Competitors
Table 20. Natpara Parathyroid Hormone Analog Major Business
Table 21. Natpara Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 22. Natpara SWOT Analysis
Table 23. Natpara Parathyroid Hormone Analog Product and Services
Table 24. Natpara Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 26. Abbott Laboratories Parathyroid Hormone Analog Major Business
Table 27. Abbott Laboratories Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 28. Abbott Laboratories SWOT Analysis
Table 29. Abbott Laboratories Parathyroid Hormone Analog Product and Services
Table 30. Abbott Laboratories Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly Parathyroid Hormone Analog Major Business
Table 33. Eli Lilly Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 34. Eli Lilly SWOT Analysis
Table 35. Eli Lilly Parathyroid Hormone Analog Product and Services
Table 36. Eli Lilly Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Parathyroid Hormone Analog Major Business
Table 39. Merck Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck Parathyroid Hormone Analog Product and Services
Table 42. Merck Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Paladin Labs Inc Basic Information, Manufacturing Base and Competitors
Table 44. Paladin Labs Inc Parathyroid Hormone Analog Major Business
Table 45. Paladin Labs Inc Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 46. Paladin Labs Inc SWOT Analysis
Table 47. Paladin Labs Inc Parathyroid Hormone Analog Product and Services
Table 48. Paladin Labs Inc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Sanofi SA Basic Information, Manufacturing Base and Competitors
Table 50. Sanofi SA Parathyroid Hormone Analog Major Business
Table 51. Sanofi SA Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 52. Sanofi SA SWOT Analysis
Table 53. Sanofi SA Parathyroid Hormone Analog Product and Services
Table 54. Sanofi SA Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 56. GlaxoSmithKline Plc Parathyroid Hormone Analog Major Business
Table 57. GlaxoSmithKline Plc Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 58. GlaxoSmithKline Plc SWOT Analysis
Table 59. GlaxoSmithKline Plc Parathyroid Hormone Analog Product and Services
Table 60. GlaxoSmithKline Plc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. OSI Pharmaceuticals Parathyroid Hormone Analog Major Business
Table 63. OSI Pharmaceuticals Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 64. OSI Pharmaceuticals SWOT Analysis
Table 65. OSI Pharmaceuticals Parathyroid Hormone Analog Product and Services
Table 66. OSI Pharmaceuticals Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. ALZA Corporation Basic Information, Manufacturing Base and Competitors
Table 68. ALZA Corporation Parathyroid Hormone Analog Major Business
Table 69. ALZA Corporation Parathyroid Hormone Analog Total Revenue (USD Million) (2017-2018)
Table 70. ALZA Corporation SWOT Analysis
Table 71. ALZA Corporation Parathyroid Hormone Analog Product and Services
Table 72. ALZA Corporation Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Parathyroid Hormone Analog Sales by Manufacturer (2018-2019) (K Pcs)
Table 74. Global Parathyroid Hormone Analog Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Parathyroid Hormone Analog Sales by Regions (2015-2020) (K Pcs)
Table 76. Global Parathyroid Hormone Analog Sales Market Share by Regions (2015-2020)
Table 77. Global Parathyroid Hormone Analog Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Parathyroid Hormone Analog Sales by Countries (2015-2020) (K Pcs)
Table 79. North America Parathyroid Hormone Analog Sales Market Share by Countries (2015-2020)
Table 80. North America Parathyroid Hormone Analog Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Parathyroid Hormone Analog Revenue Market Share by Countries (2015-2020)
Table 82. Europe Parathyroid Hormone Analog Sales by Countries (2015-2020) (K Pcs)
Table 83. Europe Parathyroid Hormone Analog Sales Market Share by Countries (2015-2020)
Table 84. Europe Parathyroid Hormone Analog Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Parathyroid Hormone Analog Sales by Regions (2015-2020) (K Pcs)
Table 86. Asia-Pacific Parathyroid Hormone Analog Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Parathyroid Hormone Analog Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Parathyroid Hormone Analog Sales by Countries (2015-2020) (K Pcs)
Table 89. South America Parathyroid Hormone Analog Sales Market Share by Countries (2015-2020)
Table 90. South America Parathyroid Hormone Analog Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Parathyroid Hormone Analog Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Parathyroid Hormone Analog Sales by Countries (2015-2020) (K Pcs)
Table 93. Middle East & Africa Parathyroid Hormone Analog Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Parathyroid Hormone Analog Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Parathyroid Hormone Analog Revenue Market Share by Countries (2015-2020)
Table 96. Global Parathyroid Hormone Analog Sales by Type (2015-2020) (K Pcs)
Table 97. Global Parathyroid Hormone Analog Sales Share by Type (2015-2020)
Table 98. Global Parathyroid Hormone Analog Revenue by Type (2015-2020) (USD Million)
Table 99. Global Parathyroid Hormone Analog Revenue Share by Type (2015-2020)
Table 100. Global Parathyroid Hormone Analog Sales by Application (2015-2020) (K Pcs)
Table 101. Global Parathyroid Hormone Analog Sales Share by Application (2015-2020)
Table 102. Global Parathyroid Hormone Analog Sales Forecast by Regions (2021-2025) (K Pcs)
Table 103. Global Parathyroid Hormone Analog Market Share Forecast by Regions (2021-2025)
Table 104. Global Parathyroid Hormone Analog Sales Forecast by Type (2021-2025) (K Pcs)
Table 105. Global Parathyroid Hormone Analog Market Share Forecast by Type (2021-2025)
Table 106. Global Parathyroid Hormone Analog Sales Forecast by Application (2021-2025)
Table 107. Global Parathyroid Hormone Analog Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Parathyroid Hormone Analog Picture
Figure 2. Global Sales Market Share of Parathyroid Hormone Analog by Type in 2019
Figure 3. Abaloparatide Picture
Figure 4. Teriparatide Picture
Figure 5. Human Parathyroid Hormone Recombinant Picture
Figure 6. Parathyroid Hormone Analog Sales Market Share by Application in 2018
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Other Picture
Figure 10. Global Parathyroid Hormone Analog Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Parathyroid Hormone Analog Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Parathyroid Hormone Analog Sales Market Share by Manufacturer in 2019
Figure 31. Global Parathyroid Hormone Analog Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Parathyroid Hormone Analog Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Parathyroid Hormone Analog Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 36. Global Parathyroid Hormone Analog Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Parathyroid Hormone Analog Revenue Market Share by Regions (2015-2020)
Figure 38. Global Parathyroid Hormone Analog Revenue Market Share by Regions in 2018
Figure 39. North America Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
Figure 40. Europe Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
Figure 42. South America Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
Figure 44. North America Parathyroid Hormone Analog Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Parathyroid Hormone Analog Sales Market Share by Countries (2015-2020)
Figure 46. North America Parathyroid Hormone Analog Sales Market Share by Countries in 2018
Figure 47. North America Parathyroid Hormone Analog Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Parathyroid Hormone Analog Revenue Market Share by Countries in 2018
Figure 49. United States Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 50. Canada Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Mexico Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Europe Parathyroid Hormone Analog Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Parathyroid Hormone Analog Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Parathyroid Hormone Analog Revenue Market Share by Countries in 2019
Figure 55. Germany Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. UK Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. France Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Italy Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Asia-Pacific Parathyroid Hormone Analog Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Parathyroid Hormone Analog Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Parathyroid Hormone Analog Revenue Market Share by Regions 2019
Figure 63. China Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Korea Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. India Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Southeast Asia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. South America Parathyroid Hormone Analog Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Parathyroid Hormone Analog Sales Market Share by Countries in 2019
Figure 70. South America Parathyroid Hormone Analog Revenue Market Share by Countries in 2019
Figure 71. Brazil Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Argentina Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Middle East and Africa Parathyroid Hormone Analog Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Parathyroid Hormone Analog Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Parathyroid Hormone Analog Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Parathyroid Hormone Analog Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Egypt Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Turkey Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. South Africa Parathyroid Hormone Analog Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Global Parathyroid Hormone Analog Sales and Growth Rate (2021-2025) (K Pcs)
Figure 82. Global Parathyroid Hormone Analog Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Parathyroid Hormone Analog Market Forecast (2021-2025) (K Pcs)
Figure 84. Europe Sales Parathyroid Hormone Analog Market Forecast (2021-2025) (K Pcs)
Figure 85. Asia-Pacific Sales Parathyroid Hormone Analog Market Forecast (2021-2025) (K Pcs)
Figure 86. South America Sales Parathyroid Hormone Analog Market Forecast (2021-2025) (K Pcs)
Figure 87. Middle East & Africa Sales Parathyroid Hormone Analog Market Forecast (2021-2025) (K Pcs)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
副甲状腺ホルモンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Parathyroid Hormone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Parathyroid Hormone marke…- 副甲状腺障害の世界市場（～2026年） Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems. Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hy…
- ヒト成長ホルモン（hGH）の世界市場（～2026年） Growth hormone(GH),also known as somatotropin(or as human growth hormone [hGH or HGH] in its human form),is a peptide hormone that stimulates growth, cell reproduction,and cell regeneration in humans and other animals. The growing application of growth hormones in treating many diseases and conditio…
- 成長ホルモン欠乏症治療の世界市場（～2026年） Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. The primary factor contributing to the growth of global growth hormone deficie…
- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …